The global bioinformatics for genomics market was valued at USD 5.02 billion and is projected to reach a market size of USD 13.35 billion by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 15%.
A field that combines computer science, statistics, and biology is called bioinformatics for genomics. It entails the analysis and interpretation of biological data, particularly genomic data, using computational approaches. The study of an organism's complete genome, including its DNA sequence, structure, function, and evolution, is known as genomics. The past decade has seen considerable growth in this market due to advancements in next-generation sequencing (NGS) and the opening of many prestigious research institutions. Presently, the market has witnessed a notable expansion owing to skilled expertise and applications. In the future, with a focus on the integration of AI and R&D activities, significant growth is predicted.
Key Market Insights:
Approximately 57% of bioinformatics businesses offer genomics solutions. By 2025, the market for bioinformatics sequencing platforms is projected to grow to $15.98 billion. The Latin American bioinformatics market was estimated by Statista to be valued at $1.31 billion in 2022. The entire market for clinical genomics, informatics, and next-generation sequencing (NGS) was estimated to be worth 836 million USD. By 2028, the market is predicted to reach a value of around 5.9 billion US dollars. The bioinformatics error rate might be a challenge when trying to identify novel variants. For instance, less than 1,000 somatic mutations and 100,000–300,000 previously unknown SNPs are predicted to be present in each freshly sequenced genome. Sources of error can be found and reduced by implementing strict quality control procedures at different phases of the sequencing and analysis process, such as sample preparation, sequencing, and data processing.
Bioinformatics for Genomics Market Drivers:
Advancements in genomic technologies have been boosting the market.
The need for bioinformatics systems that can handle large data and complicated analysis has increased as next-generation sequencing (NGS) technology advances and makes sequencing faster, more accurate, and more affordable. This has helped in generating vast amounts of data. Besides, methods like long-read sequencing and single-cell sequencing have helped in identifying diseases and in early diagnosis as well. Furthermore, to extract useful insights and understand the intricacies of biological systems, the integration of multi-omics data, including genomes, transcriptomics, proteomics, and metabolomics, requires sophisticated bioinformatics techniques. This presents new opportunities for bioinformatics to build specialized tools for data analysis and interpretation.
Precision medicine has been accelerating the growth rate.
Genomic data plays a major role in the increasingly important field of precision medicine, which attempts to customize medical care to each patient's unique traits. When analyzing genomic data to find genetic changes linked to diseases, forecast medication responses, and create individualized treatment regimens, bioinformatics is a critical tool. The increasing demand for precision medicine activities in global healthcare systems will be driven by the bioinformatics tools and services that facilitate genomic analysis for precision medicine applications.
Bioinformatics for Genomics Market Restraints and Challenges:
Integration challenges, data privacy, computational complexities, and a shortage of personnel are the main issues that the market is currently facing.
There are a lot of obstacles to integrating and harmonizing different genomic datasets from different sources. Variations in data formats, quality, and annotation standards might hinder interoperability and complicate data analysis and interpretation. Secondly, the privacy of data is another major challenge. Sensitive information about the patient is often stored in databases. Misuse and leakage of this information can lead to significant losses. Thirdly, computationally demanding operations, including alignment, variant calling, and functional annotation, are frequently part of the processing of genomic data. Large-scale genomic dataset handling calls for effective algorithms, and high-performance computer infrastructure is required for processing this data. This can be both expensive and resource-intensive. Moreover, since this is an emerging field, there is a lack of skilled expertise. Providing sufficient education and training about the working of bioinformatics tools and genetic methods is vital.
Bioinformatics for Genomics Market Opportunities:
Through the identification of new therapeutic targets, the clarification of disease mechanisms, and the prediction of medication responses, genomic data analysis is essential to the process of drug discovery and development. The pharmaceutical sector can benefit greatly from bioinformatics tools that make it easier to analyze genomic and multi-omics data to prioritize therapeutic targets, optimize drug candidates, and stratify patient populations. Secondly, genomic data integration opens up new possibilities for bioinformatics solutions that provide seamless data interchange, interoperability, and point-of-care decision assistance within electronic health records (EHRs) and healthcare informatics systems. In healthcare settings, integrating genetic data with clinical data can improve patient outcomes, therapy selection, and disease risk assessment. Apart from this, clinical diagnostics using genomic technology are being used more and more to identify, diagnose, and track infectious illnesses, cancer, and genetic disorders. Bioinformatics tools that enable variant interpretation and reporting, as well as the interpretation of genetic data in a clinical context, provide many possibilities.
BIOINFORMATICS FOR GENOMICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
15% |
|
Segments Covered |
By Product, Application, Sector, End-Users, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Agilent Technologies, Inc., PerkinElmer, Inc., BGI Group, GENEWIZ (Brooks Automation Company), Eurofins Scientific, DNAnexus, Inc., Oxford Nanopore Technologies Ltd. |
Bioinformatics Platforms
Bioinformatics Services
Knowledge Management Tools
Bioinformatics platforms are the largest growing segment. Because bioinformatics platforms give researchers the tools and software they need to analyze and interpret genomic data, they are essential to genomic research. Numerous applications are supported by these platforms, such as structure prediction, variant calling, functional annotation, and sequence alignment. As genetic data grows exponentially and sequencing technology progresses, bioinformatics platforms adapt to accommodate the varied needs of researchers in academia, biopharmaceuticals, healthcare, and other fields. These platforms offer a growing range of sophisticated features and capabilities. Bioinformatics services are the fastest-growing category. As a vital part of the genomics landscape, bioinformatics services provide specialized knowledge and assistance for the analysis, interpretation, and application of genetic data. These services cover a wide range of products and services, such as data analysis, training, consulting, and solutions that are specially designed to meet the requirements of laboratories, institutions, and researchers. The demand for bioinformatics services is rising quickly due to the increasing complexity of genomic analyses and the growing applications of genomics in various fields like environmental science, agriculture, and personalized medicine.
Genome Sequencing
Functional Genomics
Comparative Genomics
Structural Genomics
Disease Genomics
Pharmacogenomics
Genomic sequencing is the largest growing application. The core use of genomics is genome sequencing, which involves figuring out an organism's genome's whole DNA sequence. Genome sequencing can forecast the emergence of diseases before symptoms appear by identifying abnormalities throughout the genome. This helps scientists understand and treat disease processes at the DNA level. Whole-genome, exome, and targeted sequencing are all included, which creates a large need for bioinformatics services and tools for data interpretation and analysis. Pharmacogenomics is the fastest-growing segment. This field is gaining popularity quickly because it may be used to tailor medication regimens according to a patient's genetic composition. It entails researching the effects of genetic variants on safety profiles, efficacy, and therapeutic responsiveness. The need for bioinformatics tools and services in pharmacogenomics research and clinical applications is being driven by the growing acceptance of precision medicine techniques and the growing focus on individualized healthcare solutions.
Medical Biotechnology
Forensic Biotechnology
Plant Biotechnology
Environmental Biotechnology
Others
Medical biotechnology is the largest growing category. Numerous fields are covered by medical biotechnology, such as gene therapy, personalized medicine, regenerative medicine, drug research and development, and diagnostics. The requirement for therapeutic target identification, biomarker discovery, and genomic data analysis, among other things, is what drives the demand for bioinformatics tools and services in the medical biotechnology industry. The fastest-growing segment is environmental biotechnology, which uses biotechnological concepts and methods to solve environmental problems such as waste management, pollution, the creation of renewable energy, and environmental preservation. The demand for bioinformatics solutions in environmental biotechnology research and applications is being driven by the increased emphasis on sustainability, mitigating climate change, and environmental protection.
Academic and Research Institutions
Biotechnology and Pharmaceutical Companies
Hospitals and Clinics
Contract Research Organizations
Due to their strong involvement in drug discovery, development, and clinical research, all of which significantly rely on bioinformatics for genomic tools and services, biotechnology and pharmaceutical companies are the largest growing end users. Businesses seek to find molecular signatures, genetic variations, and biomarkers linked to treatment response, illness development, and susceptibility by evaluating genomic data. Hospitals and clinics are the fastest-growing end-users. This is especially true given the growing popularity of personalized medicine, genomic diagnostics, and genomics-driven healthcare initiatives. The development of genomic technologies, growing recognition of the therapeutic utility of genomics, and the incorporation of genetic data into patient care pathways are the main drivers of this expansion.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
North America is the largest growing market. Due to the region's strong concentration of prestigious research organizations, educational institutions, and bioinformatics companies, the U.S. and Canada account for the majority of revenue generation. The regional market is anticipated to grow as a result of increased investments in the research and development of novel and advanced technologies linked to genome sequencing. Besides this, the economy in this region is stable, contributing to greater investments in research and developmental activities. Asia-Pacific is the fastest-growing market. Countries like China, India, and Japan are at the forefront. Growing government financing and initiatives for genomics research, the growing use of precision medicine and tailored healthcare solutions, the expansion of the biotechnology and pharmaceutical industries, and the development of partnerships with foreign partners are some of the factors propelling this rise. In addition, there is a big need for genomic research and healthcare applications in the Asia-Pacific area due to the region's vast population base and increased prevalence of chronic diseases.
COVID-19 Impact Analysis on the Global Bioinformatics for Genomics Market:
The outbreak of the virus had a positive impact on the market. The pandemic brought to light the significance of genetics in comprehending biology and viral dissemination. As a result, there was a demand for bioinformatics platforms and tools designed specifically for genomic study, including those for variant detection, evolutionary analysis, and viral genome sequencing. The need to create COVID-19 treatments, vaccinations, and diagnostics quickly spurred advances in genomics and bioinformatics. Globally, businesses and academic organizations have started to use bioinformatics techniques to study viral genomes, find genetic variants, and create efficient vaccinations and diagnostic tests. There was a general trend toward remote work. Despite physical barriers to collaboration, bioinformatics businesses were able to adapt by providing cloud-based platforms and remotely accessible tools that allowed researchers to examine genomic data and work together efficiently. According to the Future Science Group, 83% of researchers stated the pandemic caused a delay in their work, and many of them started conducting research remotely with a strong emphasis on computational work. Most of the funding was allotted to the pharmaceutical sector. This made research and developmental activities easier. Post-pandemic, the market has continued to grow owing to demand and efforts.
Latest Trends/ Developments:
Companies in this industry are motivated to increase their market share by using a range of strategies, including acquisitions, joint ventures, and investments. Businesses are spending a lot of money to develop techniques to retain competitive pricing. Further growth has resulted from this. Opportunities for bioinformatics solutions that assist crop improvement, livestock breeding, and sustainable agricultural practices are presented by the use of genomics in agriculture. Global food security and agricultural sustainability can be improved by using bioinformatics techniques for genomic selection, trait mapping, and marker-assisted breeding. These techniques can also increase crop output, disease resistance, and nutritional quality.
Key Players:
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Qiagen N.V.
Agilent Technologies, Inc.
PerkinElmer, Inc.
BGI Group
GENEWIZ (Brooks Automation Company)
Eurofins Scientific
DNAnexus, Inc.
Oxford Nanopore Technologies Ltd.
In February 2023, at the Advances in Genome Biology and Technology (AGBT) 2023 General Meeting, BioSkryb Genomics, a leader in complete single-cell multiomic research solutions, announced the commercial launch of its BaseJumperTM Bioinformatics Platform and ResolveOMETM Whole Genome and Transcriptome Amplification system. With ResolveOME, it is possible to accurately and thoroughly examine the whole genome, transcriptome, exomes, or specific gene content of a single cell for the first time in the single-cell analysis market.
In January 2023, the bioinformatics company QIAGEN, QIAGEN Digital Insights (QDI), announced the release of their improved QIAGEN CLC Genomics Workbench Premium, which adds revolutionary analysis speed to analyze and interpret large panel sequencing, whole exome sequencing, and whole genome sequencing (WGS) data, thereby eliminating the data-analysis bottleneck of next-generation sequencing (NGS).
In March 2022, ARUP introduced Rio, a new bioinformatics platform that was launched to enhance the precision and speed of next-generation sequencing (NGS) test outcomes. Rio leverages cloud computing to transfer data more effectively and precisely, enabling doctors to analyze test findings more quickly and make better patient decisions.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The global bioinformatics for genomics market was valued at USD 5.02 billion and is projected to reach a market size of USD 13.35 billion by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 15%.
Advancements in genomic technologies and precision medicine are the main factors propelling global bioinformatics for the genomics market.
Based on product, the global bioinformatics for genomics market is segmented into bioinformatics platforms, bioinformatics services, and knowledge management tools.
North America is the most dominant region for global bioinformatics in the genomics market.
Illumina, Inc., Thermo Fisher Scientific, Inc., and Qiagen N.V. are the key players operating in global bioinformatics for the genomics market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
